T 0455/96 (Blood substitute/BIOPURE CORPORATION) of 16.07.2002
- European Case Law Identifier
- ECLI:EP:BA:2002:T045596.20020716
- Date of decision
- 16 July 2002
- Case number
- T 0455/96
- Petition for review of
- -
- Application number
- 87116556.9
- IPC class
- A61K 37/14
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Extra pure semi-synthetic blood substitute
- Applicant name
- Biopure Corporation
- Opponent name
- (01) Baxter International Inc.
(02) Enzon, Inc.
(03) Somatogen Inc.
(04) Hemosol, Inc.
(05) Stichting Centraal Laboratorium van de
Bloedtransfusiedienst van het Nederlandse Rode Kruis
(06) Northfield Laboratories, Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973European Patent Convention Art 84 1973
- Keywords
- Main request: sufficiency of disclosure (yes), inventive step (yes)
- Catchword
- -
- Citing cases
- T 0882/01
ORDER
For these reasons it is decided:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent as requested by the appellant.